The 1 analysts offering 12-month price forecasts for Zomedica Corp have a median target of 0.44, with a high estimate of 0.44 and a low estimate of 0.44. The median estimate represents a +160.66% increase from the last price of 0.17.
The current consensus among 1 polled investment analysts is to Hold stock in Zomedica Corp. This rating has held steady since November, when it was downgraded from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.00
Reporting Date Feb 28
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.